Skip to main content
    O

    Omnicell Inc (OMCL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $35.44
    +0.41 (+1.17%)

    Market Cap: $1.61B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Omnicell Inc (OMCL) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Omnicell reported revenue of $1.18B for the fiscal year ended Dec 31, 2025, up 6.5% from the year before. That year, net income was $2.05M with a net margin of 0.2%, operating cash flow was $127.30M and free cash flow was $86.89M. The quarter ended Sep 30, 2026 had revenue of $307.85M and net income of $11.04M.

    Revenue and Margins

    The operating margin was 0.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $695.91M, a compound annual rate of 6.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.18B+6.5%42.5%0.4%0.2%
    Dec 2024$1.11B-3.0%42.3%0.0%1.1%
    Dec 2023$1.15B-11.5%43.3%-3.0%-1.8%
    Dec 2022$1.30B+14.5%45.4%-0.2%0.4%
    Dec 2021$1.13B+26.9%49.0%7.9%6.9%
    Dec 2020$892.21M-0.5%46.3%4.0%3.6%
    Dec 2019$897.03M+13.9%48.7%8.7%6.8%
    Dec 2018$787.31M+10.5%47.3%5.6%4.8%
    Dec 2017$712.71M+2.4%44.7%1.6%4.3%
    Dec 2016$695.91MN/A45.6%3.1%1.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 83.6% from the year before. In the quarter ended Sep 2026, net income rose 102.2% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.18B$1.11B$1.15B$1.30B$1.13B$892.21M$897.03M$787.31M$712.71M$695.91M
    Cost of revenue$681.40M$641.24M$650.27M$706.96M$577.37M$478.92M$460.12M$414.98M$394.08M$378.82M
    Gross profit$503.44M$471.00M$496.84M$588.99M$554.65M$413.29M$436.91M$372.33M$318.64M$317.08M
    Research and development$88.67M$90.41M$97.11M$104.97M$75.72M$70.16M$68.64M$64.84M$66.02M$57.80M
    Operating income$5.16M$337.00K-$34.87M-$2.32M$89.51M$35.53M$78.35M$44.39M$11.14M$21.41M
    Net income$2.05M$12.53M-$20.37M$5.65M$77.85M$32.19M$61.34M$37.73M$30.52M$9.76M
    EBITDA$100.61M$119.14M$79.85M$100.88M$172.99M$107.31M$140.26M$89.26M$57.61M$72.93M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$307.85M$312.21M$309.88M$313.98M$310.63M$290.56M$269.67M$306.88M$282.42M$276.79M$246.15M$258.85M
    Gross profit$137.83M$152.94M$140.36M$130.32M$134.50M$127.68M$110.94M$141.76M$122.27M$114.35M$92.62M$105.40M
    Operating income$14.93M$32.45M$16.85M$415.00K$8.24M$8.12M-$11.62M$12.40M$6.56M$3.22M-$21.85M-$23.36M
    Net income$11.04M$24.29M$11.36M-$2.03M$5.46M$5.64M-$7.02M$15.84M$8.63M$3.73M-$15.68M-$14.38M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $179.55M by $16.97M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.97B$2.12B$2.23B$2.21B$2.14B$1.82B$1.24B$1.08B$1.02B$935.10M
    Current assets$680.07M$815.49M$927.57M$881.81M$780.70M$829.41M$483.24M$397.13M$352.27M$315.41M
    Cash and equivalents$196.52M$369.20M$467.97M$330.36M$349.05M$485.93M$127.21M$67.19M$32.42M$54.49M
    Total liabilities$742.91M$877.65M$1.04B$1.08B$995.81M$857.00M$395.56M$401.63M$462.02M$503.50M
    Short-term debt$11.96M$174.32M$0$10.76M$488.15M$0$10.06M$8.99M$15.21M$8.41M
    Long-term debt$167.60M$166.40M$569.66M$566.57M$0$467.20M$50.00M$135.42M$194.92M$245.73M
    Shareholder equity$1.23B$1.24B$1.19B$1.13B$1.15B$967.50M$845.25M$679.62M$554.34M$431.61M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.06B$2.00B$2.00B$1.97B$1.95B$2.15B$2.15B$2.12B$2.30B$2.29B$2.28B$2.23B
    Total liabilities$739.58M$707.25M$747.48M$742.91M$727.70M$881.88M$894.37M$877.65M$1.07B$1.09B$1.10B$1.04B
    Cash and equivalents$314.86M$292.17M$239.22M$196.52M$180.05M$399.00M$386.83M$369.20M$570.63M$556.78M$512.36M$467.97M
    Shareholder equity$1.32B$1.29B$1.26B$1.23B$1.22B$1.26B$1.26B$1.24B$1.23B$1.20B$1.19B$1.19B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 68.3% of operating cash flow. Share repurchases came to 89.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$127.30M$187.72M$181.09M$77.78M$231.81M$185.87M$145.01M$103.97M$24.83M$49.90M
    Capital expenditures$40.41M$36.46M$41.47M$47.54M$28.97M$22.84M$15.89M$23.70M$15.34M$13.45M
    Free cash flow$86.89M$151.26M$139.62M$30.25M$202.84M$163.03M$129.11M$80.27M$9.49M$36.45M
    Dividends paidN/AN/A$4.40MN/AN/A$105.56M$9.67MN/A$0$0
    Share repurchases$77.60M$0$0$52.21M$0$53.03M$0$0N/AN/A
    Investing cash flow-$60.36M-$52.79M-$55.02M-$58.67M-$412.50M-$279.87M-$61.66M-$54.37M-$34.99M-$341.32M
    Financing cash flow-$218.32M-$235.58M$23.42M-$20.95M$47.36M$456.27M-$23.48M-$13.60M-$9.88M$263.75M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$33.05M$68.31M$54.50M$30.35M$28.27M$42.76M$25.92M$56.31M$22.75M$58.70M$49.95M$38.41M
    Capital expenditures$11.36M$8.94M$12.44M$7.71M$9.75M$11.78M$11.17M$9.09M$8.87M$9.55M$8.96M$9.07M
    Free cash flow$21.69M$59.37M$42.06M$22.64M$18.51M$30.97M$14.75M$47.23M$13.89M$49.15M$41.00M$29.34M
    Last 12 quarters

    Frequently Asked Questions About OMCL

    What is Omnicell's annual revenue?

    Omnicell reported revenue of $1.18B for the fiscal year ended Dec 31, 2025.

    How fast is Omnicell's revenue growing?

    Revenue was up 6.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.9%.

    Is Omnicell profitable?

    Yes. Omnicell reported net income of $2.05M for the fiscal year ended Dec 31, 2025, with a net margin of 0.2%.

    How much free cash flow does OMCL generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $127.30M minus capital expenditures of $40.41M produced free cash flow of $86.89M.

    How much debt does Omnicell have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $167.60M, short-term debt of $11.96M and cash and equivalents of $196.52M.